Effects of statins, fibrates, rosuvastatin, and ezetimibe beyond cholesterol: The modulation of LDL size and subclasses in high-risk patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Link
http://link.springer.com/content/pdf/10.1007/BF02848780.pdf
Reference39 articles.
1. Krauss RM. Dietary and genetic probes of atherogenic dyslipidemia.Arterioscler Thromb Vasc Biol. 2005; 25: 2265–2272.
2. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity.J Lipid Res. 2002; 43: 1363–1379.
3. Georgieva AM, van Greevenbroek MMJ, Krauss RM, et al. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.Arterioscler Thromb Vasc Biol. 2004; 24: 1–7.
4. Rizzo M, Berneis K. Should we measure routinely the LDL peak particle size?Int J Cardiol. 2006; 107: 147–151.
5. National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.Circulation. 2002; 106: 3143–3421.
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rosuvastatin inhibit ox-LDL-induced platelet activation by the p38/MAPK pathway;Clinical Hemorheology and Microcirculation;2024-09-13
2. PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid‐lowering effects;Journal of Cellular and Molecular Medicine;2019-09-26
3. SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS;Rational Pharmacotherapy in Cardiology;2017-01-01
4. Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future: Table 1.;International Journal of Epidemiology;2016-10
5. Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study;Frontiers in Pharmacology;2016-01-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3